FTA: In mice, when Dr. Isenberg and his team introduced a drug that prevented a protein, thrombospondin-1, from binding to a surface cell receptor called CD47, the animals could endure almost unheard-of doses of radiation with virtually no ill effects.

This is from late 2009. Does anyone have an update on this research? Would obviously be a great boon if it was equally effective in humans.